| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/06/1999 | EP0912558A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 05/06/1999 | EP0912551A1 Somatostatin agonists and antagonists |
| 05/06/1999 | EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 05/06/1999 | EP0912505A1 Il-8 receptor antagonists |
| 05/06/1999 | EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds |
| 05/06/1999 | EP0912487A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors |
| 05/06/1999 | EP0912189A1 Use of artichoke (cynara) extracts |
| 05/06/1999 | EP0912184A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 05/06/1999 | EP0772604B1 Triazole compounds and their use as dopamine-d3-ligands |
| 05/06/1999 | EP0746333B1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv) |
| 05/06/1999 | EP0654272B1 Alimentary canal cell activator |
| 05/06/1999 | EP0623114B1 Phenyl imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists |
| 05/06/1999 | CA2847985A1 Process for stereoselective synthesis of prostacyclin derivatives |
| 05/06/1999 | CA2309135A1 N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors |
| 05/06/1999 | CA2308454A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | CA2308443A1 Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors |
| 05/06/1999 | CA2308069A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | CA2307891A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 05/06/1999 | CA2307890A1 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 05/06/1999 | CA2307661A1 Cyclopentene derivatives useful as antagonists of the motilin receptor |
| 05/06/1999 | CA2307320A1 148 human secreted proteins |
| 05/06/1999 | CA2307163A1 Process for stereoselective synthesis of prostacyclin derivatives |
| 05/06/1999 | CA2305258A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 05/05/1999 | CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors |
| 05/05/1999 | CN1215996A Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 05/05/1999 | CN1215992A Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
| 05/05/1999 | CN1215597A 'Fuchang'an' for treating abdominal troubles and its preparing method |
| 05/05/1999 | CN1043230C Serotoninergic ergoline derivs. |
| 05/04/1999 | US5900434 Method for inhibiting the production of interleukin-1 or tumor necrosis factor-α by administering acanthoic acid |
| 05/04/1999 | US5900424 Omeprazole magnesium salt form |
| 05/04/1999 | US5900413 Administering with amoxicillin |
| 05/04/1999 | US5900400 Protein |
| 05/04/1999 | US5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists |
| 05/04/1999 | US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles |
| 05/04/1999 | CA2129637C Treatment for inflammatory bowel disease |
| 05/03/1999 | CA2252733A1 Sulfonamide-substituted benzopyran derivatives, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them |
| 04/29/1999 | WO1999020745A1 Enteric coated microgranules for stabilizing lactic acid bacteria |
| 04/29/1999 | WO1999020633A1 Benzoxazine derivatives, preparation and application in therapy |
| 04/29/1999 | WO1999020624A1 Bicyclic kinase inhibitors |
| 04/29/1999 | WO1999020622A1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors |
| 04/29/1999 | WO1999020613A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors |
| 04/29/1999 | WO1999020601A1 α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 04/29/1999 | WO1999020599A1 Pharmaceutically active compounds and methods of use |
| 04/29/1999 | WO1999020239A1 Plaque-inhibiting oral compositions |
| 04/29/1999 | DE19747063A1 New 3-substituted tetrahydropyridopyrimidinone derivatives |
| 04/29/1999 | CA2307597A1 Pharmaceutically active compounds and methods of use |
| 04/29/1999 | CA2306870A1 Bicyclic kinase inhibitors |
| 04/29/1999 | CA2305804A1 Plaque-inhibiting oral compositions |
| 04/29/1999 | CA2305798A1 .alpha.-aryl-n-alkylnitrones and pharmaceutical compositions containing the same |
| 04/28/1999 | EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5 |
| 04/28/1999 | EP0911409A2 Deformylase |
| 04/28/1999 | EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911402A2 PyrR homolog from Staphylococcus aureus |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911340A2 Substituted Isoquinolin-3-Carboxyamides, their preparation and medical use |
| 04/28/1999 | EP0911333A1 Pyrazolo[4,3-d]pyrimidine derivatives and pharmaceutical compositions containing them |
| 04/28/1999 | EP0911331A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 04/28/1999 | EP0911038A1 Anhydrous composition comprising lactulose |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 04/28/1999 | EP0910566A1 Heterocyclic compounds and their preparation and use |
| 04/28/1999 | EP0910564A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 04/28/1999 | EP0910428A1 Photopheresis treatment of chronic hcv infections |
| 04/28/1999 | EP0910388A1 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease |
| 04/28/1999 | EP0910378A1 Methods of increasing sphincter competence |
| 04/28/1999 | EP0910376A2 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 04/28/1999 | EP0910359A1 Selection and/or enhancement of resident microorganisms in the gastrointestinal tract |
| 04/28/1999 | EP0910358A1 Phenyl derivatives useful as blockers of chloride channels |
| 04/28/1999 | EP0910348A1 Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof |
| 04/28/1999 | EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/28/1999 | EP0679092B1 Cytokine restraining agents |
| 04/28/1999 | EP0609328B1 Pyrrolo-pyridazines with gastro-intestinal protective action |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215401A 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives endothelin antagonists |
| 04/28/1999 | CN1215391A 6-phenylpyridyl-2-amine derivatives |
| 04/28/1999 | CN1215333A Use of derivativ |
| 04/28/1999 | CN1214921A Weikangning powder for gastric disease |
| 04/28/1999 | CN1214910A Pharmaceutical application of crust holoside and derivant thereof |
| 04/28/1999 | CA2248270A1 Novel dbpb |
| 04/27/1999 | US5897860 Hemostatic composition; treating ulcers, suturing blood vessels, treating hemophilia, inhibiting growth of microrganisms |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/22/1999 | WO1999019732A1 Methods and compositions for detecting hepatitis e virus |
| 04/22/1999 | WO1999019477A1 Cadherin derived growth factor and the application thereof |
| 04/22/1999 | WO1999019354A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | WO1999019346A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin |
| 04/22/1999 | WO1999019325A1 8-azabicyclo [3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 04/22/1999 | WO1999019320A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/22/1999 | WO1999018999A1 Compositions for controlling bacterial colonization |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018962A1 Pharmaceutically active compound and methods of use |
| 04/22/1999 | WO1999018959A1 Pharmaceutical formulation comprising glycine as a stabilizer |
| 04/22/1999 | WO1999018952A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 04/22/1999 | WO1999018938A1 Delayed total release gastrointestinal drug delivery system |
| 04/22/1999 | WO1999018935A1 Preparation of a directly mouldable tabletting auxiliary |
| 04/22/1999 | WO1999018801A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | WO1999006361A3 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | WO1998050383A8 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands |
| 04/22/1999 | DE19845339A1 Directly compressible tabletting aid |
| 04/22/1999 | CA2308143A1 Pharmaceutical formulation comprising glycine as a stabilizer |